Results 181 to 190 of about 21,677 (225)

Xuetongsu attenuates bone destruction in rheumatoid arthritis by suppressing RANKL/RANK/NFATc1 pathway to inhibit osteoclastogenesis and bone resorption. [PDF]

Bone Joint Res
Zheng H, Deng Y, Li B, Huang J, Liu J, Yang Y, Chen Y, Mao L, Li Y, Liu Y, Wang W, Yu H.   +11 more
europepmc   +1 more source

Inflammatory bone loss and signaling pathways in periodontitis: mechanistic insights and emerging therapeutic strategies. [PDF]

Bone Res
de Molon RS, Vernal R, Oliveira GE, Steffens JP, Ervolino E, Theodoro LH, van den Beucken JJJP, Tetradis S.   +7 more
europepmc   +1 more source

Dual Osteoprotective Actions of the Kefir Peptide KFP-1: Enhancement of Bone Formation and Suppression of Bone Resorption in Cells and Murine Models. [PDF]

Calcif Tissue Int
Tung MC, Chang GR, Tu MY, Fan HC, Yen CC, Cidem A, Chen IC, Chen CM.   +7 more
europepmc   +1 more source

NFATc1 regulates LAG3+CD8+ T cells in the spleen of mice infected with Plasmodium yoelii NSM. [PDF]

PLoS Negl Trop Dis
Pan X, Mo F, Pan L, Xiao W, Liang G, Xie X, Yuan H, Wei H, Zhao S, Li L, Jia L, Xie H, Huang J.   +12 more
europepmc   +1 more source

Obestatin treatment links mitochondrial homeostasis and skeletal muscle repair in Duchenne muscle dystrophy. [PDF]

Mol Biomed
Lodeiro AC, Costas-Abalde S, Cid-Díaz T, Debasa-Corral L, Leal-López S, Mamchaoui K, Mouly V, Casabiell X, Gallego R, Relova JL, Pazos Y, Santos-Zas I, Camiña JP.   +12 more
europepmc   +1 more source

TSP-1 interaction with RANK and OPG: implications for bone remodeling and osteolytic bone metastasis. [PDF]

Cell Death Dis
Carminati L, Sangalli F, Urbinati C, Longhi E, Tomasoni G, Borsotti P, Midwood KS, Carlessi E, Rusnati M, Taraboletti G.   +9 more
europepmc   +1 more source

Mycl, activated by Sgk1-phosphorylated Stat3, mediates osteoclastogenesis via Ctsk transcriptional regulation. [PDF]

Sci Rep
Wang Y, Yang C, Cao F, Zhang Y, Li M, Zhang Y, Sheng C, Shao L.   +7 more
europepmc   +1 more source

MSDC-0160, a novel clinical-stage mitochondrial pyruvate carrier inhibitor, suppresses osteoclast differentiation and alleviates type 2 diabetes-related bone loss. [PDF]

J Transl Med
Wang C, Hai N, Chen L, Huang Q, Gui Y, Su Y, Lian H, Liang J, Zhao J, Xu J, Liu Q.   +10 more
europepmc   +1 more source

Pre-therapeutic bone marrow-resident leukemic cells in acute myeloid leukemia exhibit a distinct dysregulated calcium signature and stem-like profile reflecting minimal residual disease precursors. [PDF]

J Exp Clin Cancer Res
Titah S, Guillemette A, Lewuillon C, Shaik FA, Berthon C, Goursaud L, Tardivel M, Bongiovanni A, Chauvet P, Jouy N, Peyrouze P, Cheok M, Brinster C, Manier S, Tarhan MÇ, Lemonnier L, Quesnel B, Touil Y.   +17 more
europepmc   +1 more source